Physicians Healthsource Inc v. Cephalon Inc, No. 18-3609 (3d Cir. 2020)Annotate this Case
Dr. Martinez, who worked for PHI, met with Cephalon representatives to discuss Cephalon drugs. Cephalon representatives asked Martinez if they could follow up with him and “send [him] things,” after which faxes were sometimes then sent. Martinez never told Cephalon or its representatives to stop sending faxes. One 2009 fax, addressed to Martinez, was an invitation to a dinner meeting program on a drug called AMRIX®; another was an invitation to a promotional product lunch on FENTORA®. Both are drugs that Martinez had discussed with Cephalon representatives previously. Neither fax included opt-out language. PHI provided its fax number to Cephalon via business cards. PHI filed a putative class action under the Telephone Consumer Protection Act, 47 U.S.C. 227, seeking actual monetary losses or statutory damages, because Cephalon sent unsolicited faxes that failed to contain opt-out notices. The Third Circuit affirmed summary judgment in favor of Cephalon. The faxes were solicited and the Act does not require solicited faxes to contain opt-out notices. The voluntary provision of a fax number constitutes express consent, invitation, and permission.